Feb 6 (Reuters) - Coya Therapeutics Inc COYA.O:
COYA THERAPEUTICS INC - REPORTS SIGNIFICANT IMPROVEMENT IN INFLAMMATORY MARKERS IN ALZHEIMER'S PATIENTS
COYA THERAPEUTICS INC - MONTHLY LD IL-2 SHOWS SIGNIFICANT REDUCTION IN CCL2 AND IL-15, INCREASE IN IL-4
COYA THERAPEUTICS INC - LD IL-2 WELL-TOLERATED WITH NO SERIOUS ADVERSE EVENTS REPORTED
Source text: ID:nBwbTXTkza
Further company coverage: COYA.O